239 related articles for article (PubMed ID: 33127864)
1. Management of menopausal symptoms and ovarian function preservation in women with gynecological cancer.
Brennan A; Brennan D; Rees M; Hickey M
Int J Gynecol Cancer; 2021 Mar; 31(3):352-359. PubMed ID: 33127864
[TBL] [Abstract][Full Text] [Related]
2. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
Rees M; Angioli R; Coleman RL; Glasspool R; Plotti F; Simoncini T; Terranova C
Maturitas; 2020 Apr; 134():56-61. PubMed ID: 32059825
[TBL] [Abstract][Full Text] [Related]
3. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
Rees M; Angioli R; Coleman RL; Glasspool RM; Plotti F; Simoncini T; Terranova C
Int J Gynecol Cancer; 2020 Apr; 30(4):428-433. PubMed ID: 32046979
[TBL] [Abstract][Full Text] [Related]
4. Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66.
Manchanda R; Gaba F; Talaulikar V; Pundir J; Gessler S; Davies M; Menon U;
BJOG; 2022 Jan; 129(1):e16-e34. PubMed ID: 34672090
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
Hall E; Finch A; Jacobson M; Rosen B; Metcalfe K; Sun P; Narod SA; Kotsopoulos J
Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
[TBL] [Abstract][Full Text] [Related]
7. Management of menopausal symptoms in women with gynecologic cancers.
Del Carmen MG; Rice LW
Gynecol Oncol; 2017 Aug; 146(2):427-435. PubMed ID: 28625396
[TBL] [Abstract][Full Text] [Related]
8. Estrogen therapy in gynecological cancer survivors.
Guidozzi F
Climacteric; 2013 Dec; 16(6):611-7. PubMed ID: 23952524
[TBL] [Abstract][Full Text] [Related]
9. Clinical Effects of Early or Surgical Menopause.
Kingsberg SA; Larkin LC; Liu JH
Obstet Gynecol; 2020 Apr; 135(4):853-868. PubMed ID: 32168205
[TBL] [Abstract][Full Text] [Related]
10. Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
Gasparri ML; Taghavi K; Fiacco E; Zuber V; Di Micco R; Gazzetta G; Valentini A; Mueller MD; Papadia A; Gentilini OD
Medicina (Kaunas); 2019 Jul; 55(8):. PubMed ID: 31362334
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation.
Guidozzi F
Climacteric; 2016 Oct; 19(5):419-22. PubMed ID: 27426853
[TBL] [Abstract][Full Text] [Related]
12. The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
Kershaw V; Hickey I; Wyld L; Jha S
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():7-17. PubMed ID: 34416580
[TBL] [Abstract][Full Text] [Related]
13. What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women.
Hickey M; Trainer A; Braat S; Davey MA; Krejany E; Wark J
BMJ Open; 2017 Nov; 7(11):e018758. PubMed ID: 29138210
[TBL] [Abstract][Full Text] [Related]
14. Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer.
Nappi RE; Cassani C; Rossi M; Zanellini F; Spinillo A
Minerva Ginecol; 2016 Oct; 68(5):602-12. PubMed ID: 26928421
[TBL] [Abstract][Full Text] [Related]
15. Managing menopausal symptoms after gynecological cancer.
Michaelson-Cohen R; Beller U
Curr Opin Oncol; 2009 Sep; 21(5):407-11. PubMed ID: 19587594
[TBL] [Abstract][Full Text] [Related]
16. Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy.
Stuursma A; van Driel CMG; Wessels NJ; de Bock GH; Mourits MJE
Maturitas; 2018 May; 111():69-76. PubMed ID: 29673834
[TBL] [Abstract][Full Text] [Related]
17. Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy.
Tucker PE; Cohen PA
Int J Gynecol Cancer; 2017 May; 27(4):847-852. PubMed ID: 28333842
[TBL] [Abstract][Full Text] [Related]
18. Genetic predisposition in gynecologic cancers.
Daniels MS; Lu KH
Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers.
Gaba F; Manchanda R
Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():46-65. PubMed ID: 32192936
[TBL] [Abstract][Full Text] [Related]
20. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
